Effects of disruption from COVID-19 on antimalarial strategies

Nat Med. 2020 Sep;26(9):1334-1336. doi: 10.1038/s41591-020-1047-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimalarials / therapeutic use*
  • Betacoronavirus / pathogenicity
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / parasitology
  • Coronavirus Infections / virology
  • Humans
  • Malaria / complications
  • Malaria / drug therapy*
  • Malaria / parasitology
  • Malaria / virology
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / parasitology
  • Pneumonia, Viral / virology
  • SARS-CoV-2

Substances

  • Antimalarials